'''Etamivan''' ([[International Nonproprietary Name|INN]], or '''ethamivan''' ([[United States Adopted Name|USAN]]); trade names '''Analepticon''' and '''Vandid''') is a [[respiratory stimulant]] drug<ref>Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. ''Journal of Pharmacology and Experimental Therapeutics''. 1975 May;193(2):657-63.</ref> related to [[nikethamide]]. It was mainly used in the treatment of [[barbiturate]] [[overdose]]<ref>Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. ''Canadian Medical Association Journal''. 1963 Jul 6;89:20-2.</ref> and [[chronic obstructive pulmonary disease]],<ref>Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. ''Canadian Medical Association Journal''. 1964 Dec 5;91:1203-8.</ref> but has now largely fallen into disuse.
